BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7435501)

  • 1. 31P NMR spectroscopy of erythrocytes in congenital hemolytic anemias: detection of heterogeneous erythrocyte populations and quantification of intracellular 2,3-diphosphoglycerate.
    Labotka RJ; Honig GR
    Am J Hematol; 1980; 9(1):55-65. PubMed ID: 7435501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular free magnesium and phosphorylated metabolites in hexokinase- and pyruvate kinase-deficient red cells measured using 31P-NMR spectroscopy.
    Ouwerkerk R; van Echteld CJ; Staal GE; Rijksen G
    Biochim Biophys Acta; 1989 Mar; 1010(3):294-303. PubMed ID: 2920177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte pyruvate kinase deficiency. The influence of physiologically important metabolites on the function of normal and defective enzymes.
    Lakomek M; Winkler H; Pekrun A; Krüger N; Sander M; Huppke P; Schröter W
    Enzyme Protein; 1994-1995; 48(3):149-63. PubMed ID: 8589802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 31P NMR measurements of intracellular pH and 2,3-diphosphoglycerate in erythrocytes.
    Petersen A; Jacobsen JP; Hørder M
    Scand J Clin Lab Invest; 1987 May; 47(3):233-7. PubMed ID: 3589487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oxygenation curves in enzymopathic hemolytic anemias].
    Rotrekl B; Prokopová M
    Acta Univ Palacki Olomuc Fac Med; 1984; 106():123-31. PubMed ID: 6242617
    [No Abstract]   [Full Text] [Related]  

  • 6. Impaired erythrocyte phosphoribosylpyrophosphate formation in hemolytic anemia due to pyruvate kinase deficiency.
    Zerez CR; Wong MD; Lachant NA; Tanaka KR
    Blood; 1988 Aug; 72(2):500-6. PubMed ID: 2456795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 31P-NMR measurements of ATP, ADP, 2,3-diphosphoglycerate and Mg2+ in human erythrocytes.
    Petersen A; Kristensen SR; Jacobsen JP; Hørder M
    Biochim Biophys Acta; 1990 Aug; 1035(2):169-74. PubMed ID: 2393665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cadmium ions on 2,3-bisphosphoglycerate in erythrocytes studied with 31P NMR.
    Arkowitz R; Hoehn-Berlage M; Gersonde K
    FEBS Lett; 1987 Jun; 217(1):21-4. PubMed ID: 3595843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo metabolic studies of glucose, ATP and 2,3-DPG in beta-thalassaemia intermedia, heterozygous beta-thalassaemic and normal erythrocytes: 13C and 31P MRS studies.
    Ting YL; Naccarato S; Qualtieri A; Chidichimo G; Brancati C
    Br J Haematol; 1994 Nov; 88(3):547-54. PubMed ID: 7819067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of erythrocyte metabolism using 31P NMR-spectroscopy].
    Cernay P; Gajdos M; Zalibera L; Golier I
    Bratisl Lek Listy; 1986 Sep; 86(3):273-80. PubMed ID: 3756559
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemoglobin affinity for 2,3-bisphosphoglycerate in solutions and intact erythrocytes: studies using pulsed-field gradient nuclear magnetic resonance and Monte Carlo simulations.
    Lennon AJ; Scott NR; Chapman BE; Kuchel PW
    Biophys J; 1994 Nov; 67(5):2096-109. PubMed ID: 7858147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorus-31 nuclear magnetic resonance measurements of 2,3-DPG degradation in human adult and cord blood erythrocytes.
    Zwerling HK; Diamond JN; Levy GC; Clark DA
    Magn Reson Med; 1986 Feb; 3(1):10-4. PubMed ID: 3959872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regeneration of phosphorylated metabolites in stored erythrocytes in an open perfusion system: studies using 31P NMR spectroscopy.
    Chapman BE; Kuchel PW; Lovric VA; Raftos JE; Stewart IM
    Br J Haematol; 1985 Nov; 61(3):385-92. PubMed ID: 4063202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [31P-NMR study of kinetics of 2,3-diphosphoglycerate degradation in human erythrocytes during their depletion].
    Ataullakhanov FI; Vitvitskiĭ VM; Dubinskaia EI; Dubinskiĭ VZ
    Biokhimiia; 1985 Aug; 50(8):1319-22. PubMed ID: 4074797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte fructose 2,6-bisphosphate content in congenital hemolytic anemias.
    Colomer D; Pujades A; Carballo E; Vives Corrons JL
    Hemoglobin; 1991; 15(6):517-23. PubMed ID: 1667653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 31P NMR relaxation time studies of 2,3-diphosphoglycerate in solution and intact erythrocytes.
    Christensen M; Jacobsen JP
    Magn Reson Med; 1988 Jun; 7(2):197-203. PubMed ID: 3398766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inappropriately low red cell 2,3-diphosphoglycerate and p50 in transfused beta-thalassemia.
    Correra A; Graziano JH; Seaman C; Piomelli S
    Blood; 1984 Apr; 63(4):803-6. PubMed ID: 6704541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anemia 2,3-DPG and tissue oxygenation in beta-thalassemia heterozygotes].
    Tassiopoulos T; Kaltsoya-Tassiopoulos A; Alchanati N; Rombos J; Pournaras N; Fessas P
    Nouv Rev Fr Hematol (1978); 1982; 24(6):359-62. PubMed ID: 7167385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organic phosphate binding to hemoglobin in intact human erythrocytes determined by 31P nuclear magnetic resonance spectroscopy.
    Marshall WE; Costello AJ; Henderson TO; Omachi A
    Biochim Biophys Acta; 1977 Feb; 490(2):290-300. PubMed ID: 13855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of phosphorylated metabolites and magnesium in the red cells of a patient with hyperactive pyruvate kinase.
    Ouwerkerk R; van Echteld CJ; Staal GE; Rijksen G
    Blood; 1988 Oct; 72(4):1224-9. PubMed ID: 3167205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.